In a recent study published this week, researchers from Saudi Arabia have identified early cardiovascular risks emerging in adults as young as their late 30s, challenging long-held assumptions about when heart disease begins to develop. The findings, drawn from a longitudinal analysis of over 12,000 Middle Eastern adults, reveal that subclinical atherosclerosis — detectable thickening of arterial walls — can begin decades before symptoms appear, particularly in individuals with central obesity and insulin resistance. This shifts the paradigm of preventive cardiology toward earlier intervention, even in populations previously considered low-risk.
In Plain English: The Clinical Takeaway
- Heart damage can start silently in your late 30s, long before chest pain or high blood pressure shows up.
- Waist size and blood sugar control are stronger early predictors of heart risk than weight alone.
- Waiting for symptoms to act is too late — prevention must begin in early adulthood to avoid irreversible damage.
When Does Heart Disease Really Start? New Evidence from the Gulf
The study, conducted by researchers at King Saud University and published in BMC Cardiovascular Disorders, tracked carotid intima-media thickness (CIMT) — a validated ultrasound marker of early arterial aging — in adults aged 35 to 50 with no prior history of cardiovascular events. Over a five-year period, 18% of participants aged 35–40 showed measurable CIMT thickening, a precursor to plaque formation. This was significantly associated with visceral adiposity, even when body mass index (BMI) remained within normal ranges. The mechanism involves ectopic fat accumulation around organs, which secretes inflammatory cytokines like interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), directly damaging the endothelium — the inner lining of blood vessels — and promoting oxidative stress.

This process, known as endothelial dysfunction, impairs nitric oxide bioavailability, reducing vasodilation and increasing arterial stiffness — a cascade that precedes hypertension and atherosclerosis by years. Unlike traditional risk models that focus on LDL cholesterol or smoking, this research highlights metabolically unhealthy normal weight (MUNW) individuals as a hidden high-risk group, particularly prevalent in South Asian and Middle Eastern populations due to genetic predispositions to insulin resistance.
Bridging the Gap: How This Changes Prevention in Real-World Settings
Current guidelines from the American Heart Association (AHA) and European Society of Cardiology (ESC) recommend cardiovascular risk assessment starting at age 40 for average-risk individuals. However, this data supports earlier screening — beginning at 35 — for those with elevated waist circumference (>94 cm for men, >80 cm for women) or fasting glucose ≥100 mg/dL, regardless of BMI. In the UK’s NHS, such a shift could integrate CIMT or carotid ultrasound into routine health checks for younger adults in high-prevalence ethnic groups, potentially preventing thousands of future myocardial infarctions.

In the U.S., where the CDC reports that nearly half of all adults have some form of cardiovascular disease, adopting earlier biomarkers could improve the precision of the Million Hearts® initiative. Insurance providers like Kaiser Permanente already use coronary calcium scoring in select populations; extending similar logic to carotid ultrasound in high-risk youth could yield cost-effective prevention, especially given that a single CIMT scan costs less than $100 and avoids radiation exposure.
Funding, Conflicts and Scientific Rigor
The study was funded by the Deanship of Scientific Research at King Saud University (Grant No. RG-1440-012), with no industry sponsorship. Lead author Dr. Layla Al-Malki, Associate Professor of Epidemiology, emphasized in a recent interview with Arab News that “this work was driven purely by public health urgency — we saw too many young patients presenting with heart attacks who had no ‘traditional’ risk factors.” She clarified that the research team had no financial ties to pharmaceutical or diagnostic companies, reinforcing the study’s independence.
Dr. Al-Malki’s findings align with emerging data from the PURE (Prospective Urban Rural Epidemiology) study, which similarly found that waist-to-height ratio outperforms BMI in predicting cardiovascular mortality across diverse ethnic groups. These results are not sensationalized; they reflect a growing consensus that cardiometabolic health must be assessed earlier and more nuance than current population-wide cutoffs allow.
Putting the Evidence in Context: A Global Perspective
To understand the broader implications, consider this: a 2023 meta-analysis in The Lancet Regional Health – Europe confirmed that South Asian and Middle Eastern individuals develop cardiovascular disease 5–10 years earlier than Europeans, even after adjusting for socioeconomic factors. This “early onset” phenotype is linked to higher rates of visceral fat accumulation at lower BMIs — a phenomenon sometimes termed “thin outside, fat inside” (TOFI).
Meanwhile, diagnostic accessibility remains a barrier. While carotid ultrasound is non-invasive and widely available in tertiary centers, its use in primary care is limited by training and reimbursement gaps. In contrast, the WHO’s Package of Essential Noncommunicable (PEN) Disease Interventions includes basic risk assessment but does not yet recommend imaging for asymptomatic adults under 40. Updating these guidelines could empower community health workers in regions like rural Egypt or Pakistan to identify at-risk youth using simple tape measures and glucose strips — tools already in widespread use.
Contraindications & When to Consult a Doctor
This research does not advocate for universal screening but rather targeted vigilance. Individuals with a family history of premature heart disease (before age 55 in men, 65 in women), gestational diabetes, polycystic ovary syndrome (PCOS), or those of South Asian, Middle Eastern, or Aboriginal descent should discuss early risk assessment with their clinician starting at age 35.

Seek medical advice if you experience unexplained fatigue, erectile dysfunction (a potential early marker of vascular dysfunction), or postprandial lethargy — subtle signs that may precede overt symptoms. Do not rely on weight alone; a normal BMI does not exclude risk. Conversely, avoid unnecessary testing if you are under 35 with no metabolic abnormalities — current evidence does not support population-wide imaging in low-risk youth.
Looking Ahead: Prevention Starts Earlier Than We Thought
The takeaway is not alarm, but agency. Heart disease is not inevitable — It’s often preventable when we act on the earliest biological signals, not just the latest symptoms. By redefining “at-risk” to include metabolically unhealthy individuals regardless of size, and by adopting tools like CIMT in strategic screening, healthcare systems can shift from reactive treatment to true prevention.
As Dr. Al-Malki noted, “We don’t need to wait for a heart attack to start protecting the heart. The window for intervention opens much earlier than we thought — and it’s ours to close.”
References
- Al-Malki L, et al. Early carotid intima-media thickening in metabolically unhealthy normal weight adults: a longitudinal cohort study. BMC Cardiovasc Disord. 2026;26:112. Https://doi.org/10.1186/s12872-026-02654-9
- Lear SA, et al. The effect of ethnic origin on the association between body mass index and cardiovascular disease: a pooled analysis of 97,803 participants. Lancet Reg Health Eur. 2023;14:100321. Https://doi.org/10.1016/j.lanepe.2023.100321
- Muntner P, et al. Prevalence of cardiovascular disease risk factors in the United States, 2015–2018. JAMA. 2020;323(15):1471–1480. Https://doi.org/10.1001/jama.2020.2532
- World Health Organization. Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Care in Low-Resource Settings. WHO, 2020. Https://www.who.int/publications/i/item/9789240003807
- National Heart, Lung, and Blood Institute. Carotid Intima-Media Thickness Test. NIH, 2022. Https://www.nhlbi.nih.gov/health/topics/carotid-intima-media-thickness-test